Administration of R-beta-hydroxybutyrate and related compounds in humans
AssigneeAxcess Global Sciences, LLC
InventorsRyan Lowery, Jacob Wilson, Terry LaCore
Life of this patent
Estimating the term…
Abstract
In various implementations, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to cause weight loss, weight maintenance, elevate blood ketone levels, maintain blood ketone levels, reduce blood glucose levels, maintain blood glucose levels, improve energy, focus, mood, cognitive function, or aide with neurological or inflammatory disorders and/or combinations thereof.
Claims22
A composition for administering ketone bodies to a subject, comprising:
- a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate,
- wherein the non-racemic mixture contains from approximately 90% to less than 100% of R-beta-hydroxybutyrate and from greater than 0% to approximately 10% of S-beta-hydroxybutyrate,
- wherein the composition is provided as or in a pill, tablet, capsule, powder, food product, food additive, milk, water, drinkable liquid, gel, or beverage.
A composition for administering ketone bodies to a subject, comprising:
- a dietetically or pharmaceutically acceptable carrier selected from the group consisting of pill, tablet, capsule, powder, food product, food additive, milk, water, drinkable liquid, gel, or beverage;
- and
- a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate,
- wherein the non-racemic mixture contains from approximately 90% to less than 100% of R-beta-hydroxybutyrate and from greater than 0% to approximately 10% of S-beta-hydroxybutyrate.
A composition for administering ketone bodies to a subject, comprising:
- a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate,
- wherein the non-racemic mixture contains from approximately 90% to less than 100% of R-beta-hydroxybutyrate and from greater than 0% to approximately 10% of S-beta-hydroxybutyrate,
- wherein the R-beta-hydroxybutyrate comprises at least one salt of R-beta-hydroxybutyrate and R-beta-hydroxybutyric acid.
A composition for administering ketone bodies to a subject, comprising:
- 1,3-butanediol;
- and
- a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate,
- wherein the non-racemic mixture contains from approximately 90% to less than 100% of R-beta-hydroxybutyrate and from greater than 0% to approximately 10% of S-beta-hydroxybutyrate.
Dependencies are inferred from the claim text.